Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
1.930
-0.050 (-2.53%)
At close: Oct 30, 2026, 4:00 PM EDT
1.940
+0.010 (0.52%)
After-hours: Oct 30, 2026, 5:54 PM EDT
Aytu BioPharma Employees
As of June 30, 2026, Aytu BioPharma had 76 total employees, including 75 full-time and 1 part-time employees. The number of employees decreased by 7 or 8.43% compared to the previous year. That makes Aytu BioPharma the 33,034th largest employer in the world and 4,307th in the United States.
Employees
76
Change (1Y)
-7
Growth (1Y)
-8.43%
Revenue / Employee
$757,500
Profits / Employee
-$187,526
Market Cap
20.97M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 76 | -7 | -8.43% | 75 | 1 |
| Jun 30, 2025 | 83 | -16 | -16.16% | 82 | 1 |
| Jun 30, 2024 | 99 | -51 | -34.00% | 99 | 0 |
| Jun 30, 2023 | 150 | -14 | -8.54% | 150 | 0 |
| Jun 30, 2022 | 164 | -11 | -6.29% | 164 | 0 |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 285 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| Biofrontera | 94 |
| SCYNEXIS | 18 |
| Incannex Healthcare | 12 |
| InMed Pharmaceuticals | 6 |
| Caring Brands | 3 |
AYTU News
- 5 days ago - Aytu BioPharma Proxy statement: Proxy filing - Filings
- 10 days ago - Aytu BioPharma Proxy statement: Proxy filing - Filings
- 4 weeks ago - Aytu BioPharma Transcript: Lytham Partners Fall 2026 Investor Conference - Transcripts
- 5 weeks ago - Aytu BioPharma Earnings Call Transcript: Q4 2026 - Transcripts
- 5 weeks ago - Aytu BioPharma Earnings release: Q4 2026 - Filings
- 5 weeks ago - Aytu BioPharma Annual report: Q4 2026 - Filings
- 5 weeks ago - Aytu BioPharma reports Q4 EPS 0c, consensus (35c) - TheFly
- 5 weeks ago - Aytu BioPharma Reports Fiscal 2026 Full Year and Fourth Quarter Operational and Financial Results - Accesswire